Stock Events

Stock Events

Aligos Therapeutics (ALGS) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-4

-2.42

-0.83

0.75

Details

Expected EPS

-2.156667

Actual EPS

-3.07

Surprise EPS

-0.91

Surprise Percent

+42.35%

Description

Aligos Therapeutics (ALGS) has reported earnings of -3.07 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.